Our keynotes this year offer the latest advances in systems biology and computation design for protein therapeutics. New session topics this year cover the latest developments in antibodies in cardiometabolic medicine, polyreactive antibodies, knowledge-based design and effects of antibody gene variation and usage on antibody response.
New to this conference? Preview three complimentary past presentations from our 2012 event:
- - Exploiting light chain diversity to create a fully human bispecific IgG platform technology
- Nicolas Fischer, Ph.D., Head of Research, Novimmune, Switzerland
- - Improved antibody therapies for the treatment of Clostridium difficile infection
- David P. Humphreys, Ph.D., Director, Antibody Biology, UCB Pharma, United Kingdom
- - Multi-epitopic anti-EGFR antibodies: enhancing surface downregulation by clustering
- K. Dane Wittrup, Ph.D., Professor, Massachusetts Institute of Technology
Antibody Engineering and Therapeutics will take place December 8-12, 2013, in Huntington Beach, California. If you’d like to know more about the event, download the agenda. If you’d like to join us, as a member of this LinkedIn group, you can save 20% off the starndard rate when you register to join us and mention code XD13172BLOGJP.*
Have any questions? Feel free to reach out to Jennifer Pereira at jpereira@iirusa.com.
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment